Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer—A New Diagnostic and Therapeutic Target?

Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer—A New Diagnostic and Therapeutic Target?

Several studies have demonstrated an expression of the prostate-specific membrane antigen (PSMA) in the cancer-related neovasculature of thyroid malignancies. Due to the poor prognosis and limited therapeutic options for patients with anaplastic (ATC) and poorly differentiated (PDTC) thyroid carcino...

Full description

Saved in:
Bibliographic Details
Main Authors: Sabine Wächter, Pietro Di Fazio, Elisabeth Maurer, Jerena Manoharan, Corinna Keber, Andreas Pfestroff, Damiano Librizzi, Detlef K. Bartsch, Markus Luster, Friederike Eilsberger
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
anaplastic thyroid carcinoma
poorly differentiated thyroid carcinoma
prostate-specific membrane antigen
theranostic
neovasculature
immunohistochemistry
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Online Access:https://doaj.org/article/9e1c2bdd96834eab9765d9c931a04e75
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/9e1c2bdd96834eab9765d9c931a04e75

Similar Items